Similar articles

• Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss.

  David-Neto E, Ribeiro DS, Ianhez LE, Palomino S, Saldanha LB, Arap S, Sabbaga E. David-Neto E, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):897-9. Transplant Proc. 1993. PMID: 8442259 No abstract available.
• Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.

  Woodle ES, Thistlethwaite JR, Gordon JH. Woodle ES, et al. Transplant Proc. 1996 Dec;28(6):3163-4. Transplant Proc. 1996. PMID: 8962225 Clinical Trial. No abstract available.
• Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.

  Olsen S, Hansen HE. Olsen S, et al. Transplant Proc. 1996 Feb;28(1):502-3. Transplant Proc. 1996. PMID: 8644329 No abstract available.
• Acute rejection and renal allograft outcome.

  Vanrenterghem YF. Vanrenterghem YF. Nephrol Dial Transplant. 1995;10 Suppl 1:29-31. doi: 10.1093/ndt/10.supp1.29. Nephrol Dial Transplant. 1995. PMID: 7617277 Review. No abstract available.
• Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy.

  Scholten EM, de Fijter JW, Paul LC. Scholten EM, et al. Curr Drug Targets Cardiovasc Haematol Disord. 2002 Dec;2(2):79-96. doi: 10.2174/1568006023337484. Curr Drug Targets Cardiovasc Haematol Disord. 2002. PMID: 12769650 Review.